Class information for:
Level 1: DPTO CITOL HISTOL NORMAL PATOL//4 METHYLTHIOAMPHETAMINE 4 MTA//ALDOMET

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19500 438 36.1 61%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2825 2496 CUNNINGHAMELLA BLAKESLEEANA//ANDROST 4 ENE 3 17 DIONE//ARTHROBACTER SIMPLEX

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DPTO CITOL HISTOL NORMAL PATOL Address 1 21% 1% 3
2 4 METHYLTHIOAMPHETAMINE 4 MTA Author keyword 1 50% 0% 1
3 ALDOMET Author keyword 1 50% 0% 1
4 ANTI DEPRESSANT THERAPY Author keyword 1 50% 0% 1
5 ANTIDEPRESSIVE AGENTS SECOND GENERATION Author keyword 1 50% 0% 1
6 ANTIPSYCHOTICS AND ANTIDEPRESSANTS Author keyword 1 50% 0% 1
7 APOPTOTIC DAMAGE Author keyword 1 50% 0% 1
8 ASL2 Address 1 50% 0% 1
9 BACKGROUND FINDINGS Author keyword 1 50% 0% 1
10 CASE CONTROL STUDIES Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 4 METHYLTHIOAMPHETAMINE 4 MTA 1 50% 0% 1 Search 4+METHYLTHIOAMPHETAMINE+4+MTA Search 4+METHYLTHIOAMPHETAMINE+4+MTA
2 ALDOMET 1 50% 0% 1 Search ALDOMET Search ALDOMET
3 ANTI DEPRESSANT THERAPY 1 50% 0% 1 Search ANTI+DEPRESSANT+THERAPY Search ANTI+DEPRESSANT+THERAPY
4 ANTIDEPRESSIVE AGENTS SECOND GENERATION 1 50% 0% 1 Search ANTIDEPRESSIVE+AGENTS++SECOND+GENERATION Search ANTIDEPRESSIVE+AGENTS++SECOND+GENERATION
5 ANTIPSYCHOTICS AND ANTIDEPRESSANTS 1 50% 0% 1 Search ANTIPSYCHOTICS+AND+ANTIDEPRESSANTS Search ANTIPSYCHOTICS+AND+ANTIDEPRESSANTS
6 APOPTOTIC DAMAGE 1 50% 0% 1 Search APOPTOTIC+DAMAGE Search APOPTOTIC+DAMAGE
7 BACKGROUND FINDINGS 1 50% 0% 1 Search BACKGROUND+FINDINGS Search BACKGROUND+FINDINGS
8 CASE CONTROL STUDIES 1 50% 0% 1 Search CASE+++CONTROL+STUDIES Search CASE+++CONTROL+STUDIES
9 CLINICALLY RELEVANT CONCENTRATIONS 1 50% 0% 1 Search CLINICALLY+RELEVANT+CONCENTRATIONS Search CLINICALLY+RELEVANT+CONCENTRATIONS
10 FAB TYPE 1 50% 0% 1 Search FAB+TYPE Search FAB+TYPE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 WING SOMATIC MUTATION 13 69% 3% 11
2 BENZODIAZEPINE TRANQUILIZERS 6 80% 1% 4
3 ANTIDEPRESSANTS IMIPRAMINE 5 63% 1% 5
4 HUMAN HEPATOCELLULAR CANCER 3 60% 1% 3
5 5 HT2A SEROTONINERGIC RECEPTOR 2 67% 0% 2
6 1321N1 CELLS 2 43% 1% 3
7 5 FLUOROURACIL LEUKOVORIN 1 100% 0% 2
8 GLYCERYL TRINITRATE NITROGLYCERIN 1 50% 0% 2
9 PROSTATE CANCER TISSUE 1 50% 0% 2
10 SEROTONINERGIC RECEPTOR 1 50% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer 2014 8 30 43%
Antidepressants: Influence on cancer and immunity? 2013 5 107 56%
Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry 2011 8 70 64%
Use of antidepressants and the risk of breast cancer: a meta-analysis 2012 5 50 40%
Genotoxic and carcinogenic effects of antipsychotics and antidepressants 2009 18 40 33%
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals 2009 39 257 18%
Review of the epidemiological literature on antidepressant use and breast cancer risk 2006 16 38 47%
Antidepressant drugs as a complementary therapeutic strategy in cancer 2013 3 74 31%
Genotoxicity and carcinogenicity studies of benzodiazepines 2007 7 41 46%
Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration-required preclinical in vivo studies 2015 0 24 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DPTO CITOL HISTOL NORMAL PATOL 1 21% 0.7% 3
2 ASL2 1 50% 0.2% 1
3 CLIN EPIDEMIOL BIOST 1 50% 0.2% 1
4 LIFE SCI BIOTECNOL 1 50% 0.2% 1
5 TEVA INNOVAT VENTU 1 50% 0.2% 1
6 CELLULAR MOL NEUROONCOL GRP 1 20% 0.7% 3
7 CLIN EPIDEMIOL BIOSTAT EDUC THERA 0 33% 0.2% 1
8 CLIN EPIDEMIOL COMMUNITY STUDY 0 33% 0.2% 1
9 CLIN PHARMACOL BIOPHARMACEUT 0 33% 0.2% 1
10 CNRS ERL7368 0 33% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000156662 METHAPYRILENE//ACRIVASTINE//METHAPYRILENE HYDROCHLORIDE
2 0.0000126259 SI PHARMACOL TOXICOL//MICRONUCLEI INDUCED//TUBERCULOSIS CHEMOTHERAPY
3 0.0000097515 M 3M3FBS//OC2//NPC 14686
4 0.0000095805 5HT3A//NUTR CELLULAIRE METAB//UNITE IMMUNOPHYSIOL GEN COMPAREE
5 0.0000082803 DUNN OSTEOSARCOMA//PROCARBAZINE//DNA IRONIII COMPLEX
6 0.0000071433 CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT
7 0.0000068552 ANEUPLOIDY INDUCTION//AGGREGATION EMBRYO CHIMERA//MAMMALIAN GERM CELLS
8 0.0000063544 ALKOXYCOUMARIN DEALKYLASE//PHENAZEPAM//GIDAZEPAM
9 0.0000062752 SOCIAL HLTH AFFAIRS//BREAST DISEASE//DEPRESSIVE MOOD DISORDERS
10 0.0000060439 META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE